GW Pharmaceuticals Ltd - Company Profile

Powered by

All the data and insights you need on GW Pharmaceuticals Ltd in one report.

$395 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date GW Pharmaceuticals Ltd Strategy Report

  • Understand GW Pharmaceuticals Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

GW Pharmaceuticals Ltd: Overview

Select Item

GW Pharmaceuticals Plc (GW Pharmaceuticals), a subsidiary of Jazz Pharmaceuticals, is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary plant-derived cannabinoid product platform. The company offers Sativex for the treatment of spasticity due to multiple sclerosis and Epidiolex for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome. It sells and distributes the product through strategic collaborations with other pharmaceutical companies. The company has subsidiaries in Australia, the US, England and Wales, and Guernsey. GW Pharmaceuticals is headquartered in Cambridge, England, the UK.

 Gain a 360-degree view of GW Pharmaceuticals Ltd and make more informed decisions for your business Gain a 360-degree view of GW Pharmaceuticals Ltd and make more informed decisions for your business Find out more
Headquarters United Kingdom
Address Sovereign House, Vision Park, Chivers Way, Histon, Cambridge, England, CB249BZ
Website www.gwpharm.com
Telephone 44 1223 266800
Industry Pharmaceuticals and Healthcare
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

GW Pharmaceuticals Ltd premium industry data and analytics

140+

Clinical Trials

Determine GW Pharmaceuticals Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

50+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for GW Pharmaceuticals Ltd’s relevant decision makers and contact details.

30+

Catalyst Calendar

Proactively evaluate GW Pharmaceuticals Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

30+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

15+

Pipeline Drugs

Identify which of GW Pharmaceuticals Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Sales & Consensus Forecasts

Understand the current and future drug revenue for GW Pharmaceuticals Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

2

Marketed Drugs

Understand GW Pharmaceuticals Ltd’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on GW Pharmaceuticals Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Marketed Savitex
Sativex Epidiolex
Epidiolex/Epidyolex
XYZ
XYZ
XYZ
Understand GW Pharmaceuticals Ltd portfolio and identify potential areas for collaboration Understand GW Pharmaceuticals Ltd portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters GW Pharmaceuticals Ltd Takeda Pharmaceutical Co Ltd Evotec SE Napp Pharmaceuticals Ltd Oxford BioMedica Plc
Headquarters United Kingdom Japan Germany United Kingdom United Kingdom
City Cambridge Chuo-Ku Hamburg Cambridge Oxford
State/Province England Tokyo Baden-Wurttemberg England England
No. of Employees - 49,095 5,086 194 891
Entity Type Private Public Public Private Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Aislinn Jane Doody Secretary Senior Management 2023 -
Nelly Alexandra Assistant General Counsel; Director - Global ESG Senior Management 2023 -
David Spackman Head - Marketing Europe and International Senior Management 2023 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into GW Pharmaceuticals Ltd key executives to enhance your sales strategy Gain insight into GW Pharmaceuticals Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward